A recent review suggested that the relationship between obesity and DRD2/3 availability can be best described by a nonlinear relationship,75 where tracer BP reflects changes in both receptor density and endogenous dopamine levels. Here, DRD2 is linked to obesity due to melanocortin 4 receptor deficiency.